The latest is one of the main outcomes of the hyperinflammation phase associated with severe COVID-19 cases supported by the concomitant upregulation of gal3, TNFα and IL-6 in lobar and bronchial pneumonia (22). The gene discussed is LGALS3; the disease is COVID-19.